THC

Flat at the highs with ADX 38 trend strength intact and a 10x P/E still cheap. RSI at 72 is warm and only 5.5% remains to target—this is trend money now, not valuation money. Holding, with an exit on a close below the 20-day at 241.

Up 2.83% pressing the 52-week high at 269.31, with a +30.7% month and ADX at 37 showing rare trend strength; RSI 71.8 runs hot and 25 analysts leave just 5.6% of headroom, but a 10x P/E is almost indecently cheap — staying long while tightening the trailing stop

Essentially flat at -0.18% with RSI at 69.0, 27.8% above the 50-day and just 10.0x earnings — visibly cheap for hospital services. The ledger already shows 27.6%, and it sits 2.2% off its high — position maintained.

Down 0.84% with RSI at 69.4, well above the 50-day at $201.37 and 2.0% from its high; a 10.0x multiple against a $281.91 target from 25 analysts — position maintained.

Up 2.14% into 52-week-high territory with RSI overbought at 71.3, though a 10.1x multiple against 66% EPS growth still supports it after a 27.2% month. Maintaining the long.

Down 1.95% in give-back from highs with RSI overbought at 69.4, though a 9.9x multiple against 66% EPS growth still supports it after a 23.2% month. Maintaining the long.

Up 3.3% to a new high, RSI 74 warm and only ~7% consensus upside — hold, with narrowing room ahead.

Up 1.34% with RSI overbought at 70.9, though a 9.8x multiple against 66% EPS growth still supports it after a 31.9% month. Maintaining the long.

Q2 EPS of $9.89 tripled year over year on 16% revenue growth at a 9x forward multiple; today's 1.88% dip is giveback from highs, and Wells Fargo lifted its target to $281. Maintaining the long.

Continue holding (maintaining long), explicitly without adding. Fundamentals fully support the position: a 43.7% EPS beat, full-year guidance raised by nearly three dollars, 5.0% same-facility growth and 10.1x earnings still undemanding post-revision. But RSI7 at 89.4 is extremely overbought, price is 0.02% from the 52-week high and just 5.5% from the $277 consensus target, so near-term risk/reward has turned asymmetric. The stop moves up to $236, near the top of the prior $230–240 breakout shelf (about 2.3 ATR below spot), locking in most of the move while allowing room to breathe. The $277 target matches consensus. A pullback into $240–248 — between the 20-day and the breakout shelf — would be the rational place to add.

Position: +1.9%, holding the 50-day with +22% consensus upside on the hospital operator, hold

A +6.2% week back above the 50-day; the hospital operator keeps its +24% consensus upside — hold

Down 2.15% to $194.9, -6.2% on the week by HCA association after its guide-down exposed payer-mix risk across hospitals. THC's own Q1 beat and a Moody's upgrade keep the thesis alive — Q2 has to prove the mix. Stay long, conviction trimmed.

Up 3.6% to $199.20, hospitals resurrecting for a second day as money floods old-economy healthcare; holding

Up 4.7% to $192.34, a full-blood rebound from the hospital panic — yesterday's sector guilt, today's comeback; stop stays $186, holding

Down 4.6% to $194.81 as hospital names got hit together (HCA -3.9%) — a sector move, not a story change; stop tightened to $186, holding

Down 1.2%, a fourth day of high consolidation with RSI cooling 70→66 — healthy digestion, holding

Up 0.2%, a third day of high-level chop digesting RSI 69.7; the defense-plus-momentum combo holds

Down 1.2% in a high consolidation; RSI 69 is warm so no adds — the defense-plus-momentum combo holds

+1.3% to fresh rebound highs; long +2.5%, the defense-plus-momentum combo holds

Hospital +1.2%, long +1.2%, +26% month; 10.7x, defense-plus-momentum, hold

Hospital operator +6.6% on a volume breakout; 10.6x earnings is a rare blend of defense and momentum